Over three full days hear from FDA, MHRA, and pharmaceutical industry experts as they set the framework for discussion on basic quality systems as well as the influence of ICH Q10 on the industry as a whole. As companies continue to address issues such as data integrity, the quality systems platform of ICH Q10 becomes increasingly important to understand and embrace. The 2018 ISPE Pharmaceutical Manufacturing Conference will examine common issues and address how companies can reach a quality maturity level and use knowledge and process understanding throughout the lifecycle of the product.
Pharmaceutical industry experts will share examples of broken, unreliable and reactive quality systems, and the transformation needed to move to a sustainable, predictable quality environment and concepts of Quality Risk Management through risk-based regulatory approaches.
The 2018 ISPE Pharmaceutical Manufacturing Conference is designed for a focused audience of pharmaceutical professionals from pharma, bio, and generic companies and regulatory agencies, including those at the executive and management levels, pharmaceutical scientists and engineers, manufacturing supervisors, development and production functions, audit functions, and suppliers.